Breaking News
September 24, 2018 - Florence’s Lingering Threat: Mold – Drugs.com MedNews
September 24, 2018 - For professional baseball players, faster hand-eye coordination linked to batting performance
September 24, 2018 - Bill for later school start times is defeated, but Stanford sleep specialist isn’t
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Successful recovery from addiction means more than achieving abstinence
September 24, 2018 - New nanoplatform technology may reverse drug-resistance in renal cell carcinoma
September 24, 2018 - October 1918 marks the centenary of Spanish Flu that claimed more lives than World War I
September 24, 2018 - LGBT community reports more number of poor mental health days than general population
September 24, 2018 - New research suggests power of zebrafish as tool for cancer drug discovery
September 24, 2018 - New study finds height as possible risk factor for developing varicose veins
September 24, 2018 - Researchers compare weight loss results of online and in-person diabetes prevention program
September 24, 2018 - New HER2 PET Study Uses Affibody’s ABY-025 Tracer to Individualize Breast Cancer Treatment
September 24, 2018 - Drug combination offers more effective care for patients suffering miscarriage
September 24, 2018 - Tallness linked to varicose veins, Stanford study says
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Ecstasy drug makes octopuses more social
September 24, 2018 - Immediate compression therapy could cut risk of complications after deep-vein thrombosis
September 24, 2018 - Transcatheter mitral valve repair reduces mortality for patients with mitral regurgitation
September 24, 2018 - First intracranial aneurysm patients treated with BRAVO Flow Diverter after CE mark approval
September 24, 2018 - ‘Physicians of the mouth’? Dentists absorb the medical billing drill
September 24, 2018 - People more likely to believe those with confident tone of voice than with accent
September 24, 2018 - Harmony Biosciences Presents 5-Year Data On Pitolisant At International Narcolepsy Symposium
September 24, 2018 - Blood test may identify gestational diabetes risk in first trimester
September 24, 2018 - Height may be risk factor for varicose veins | News Center
September 24, 2018 - King’s commemorates opening of new NMR facility with one-day symposium
September 24, 2018 - Eisai receives approval for partial label change of DC Bead device for transcatheter arterial embolization
September 24, 2018 - High-resolution genomic map gives scientists unprecedented view of brain development
September 24, 2018 - Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD
September 24, 2018 - First evaluation of benefits, harms of Alzheimer’s screening for family members of older adults
September 24, 2018 - Ancora Heart announces positive data of study evaluating AccuCinch Ventricular Repair System
September 24, 2018 - Children of mothers using cannabis may start using it at an earlier age, finds study
September 24, 2018 - Gilead Sciences plans to launch authorized generic versions of Epclusa and Harvoni in the US
September 24, 2018 - Most patients who underwent transcatheter valve replacement experience prosthesis-patient mismatch
September 24, 2018 - Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone
September 24, 2018 - New study provides basis for Air Canada to change its facial hair policy for aircrew
September 24, 2018 - Infant walkers lead to thousands of emergency visits for babies
September 24, 2018 - Genes predicting person’s height may provide clues about causes of varicose veins
September 24, 2018 - EPA Plan Will Maintain Carbon Emissions From Power Plants
September 24, 2018 - Characterizing pig hippocampus could improve translational neuroscience
September 24, 2018 - Element3 Health reports social and mental engagement play key role in overall health
September 24, 2018 - Paralympic medalists support Fight for Sight’s unique virtual event
September 24, 2018 - ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma
September 24, 2018 - Public awareness of urological conditions found to be alarmingly low across Europe
September 24, 2018 - Fitter Folks Suffer Milder Strokes: Study
September 24, 2018 - Novel botulinum toxin compound relieves chronic pain
September 24, 2018 - CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents
September 24, 2018 - National Friendly’s private medical insurance is a hit with women living in the South East
September 24, 2018 - Academics receive prestigious awards for achievements in blood pressure research
September 24, 2018 - Obese pregnant women can restrict weight gain safely with proper nutrition guidance
September 24, 2018 - CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer
September 24, 2018 - China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma
September 24, 2018 - A new approach for finding Alzheimer’s treatments
September 24, 2018 - USC research uncovers previously unknown genetic risk factor for dementia
September 24, 2018 - Study examining mental health among students finds significant disparities in treatment across race
September 24, 2018 - Breakthrough discovery paves way for future test to identify drowsy drivers
September 24, 2018 - Transcatheter mitral-valve repair in patients with heart failure
September 24, 2018 - Study opens new avenues for treatment of Laing distal myopathy
September 24, 2018 - Stroke Facts | cdc.gov
September 24, 2018 - Sarcolipin tricks muscle cells into using more energy, burning fat
September 24, 2018 - Enrollment in opioid controlled substance agreement reduces primary care visits
September 24, 2018 - UTA researchers patent new smart seat cushion technology that helps prevent painful ulcers
September 24, 2018 - Second HPV-Related Primary Cancers Common in Survivors
September 24, 2018 - How a virus destabilizes the genome
September 24, 2018 - Old letters provide insight into Spanish flu pandemic horror
September 23, 2018 - Smart textile-based soft robotic exosuit helps wearers save energy and traverse difficult terrain
September 23, 2018 - New research hub to drive radical change in development and manufacturing of vaccines
September 23, 2018 - AHA: For Hispanics, Neighborhood May Be Key Factor in Heart Disease Risk
September 23, 2018 - Excessive airway nerves tied to more severe asthma symptoms, study finds
September 23, 2018 - Study highlights need to remain vigilant in maintaining key infection control processes
September 23, 2018 - Novel therapeutic strategy for blood vessel related disorders, such as cancer and retinopathy
September 23, 2018 - New naturally occurring antibiotic found effective against Mycobacterium tuberculosis
September 23, 2018 - First-in-human phase 0 study shows clinically-relevant activity of new drug in glioblastoma
September 23, 2018 - Removing tobacco product display from shops reduced number of children buying cigarettes
September 23, 2018 - Random fraction of specialized immune cells leads the charge in battling invaders
September 23, 2018 - Few minutes of sprinting exercise may be as effective as longer exercise sessions
September 23, 2018 - Researchers use neutrons to make first direct observations of water in lipid bilayers
September 23, 2018 - Researchers demonstrate pre-clinical success for universal flu vaccine in new paper
September 23, 2018 - Study reveals surprising gaps in some HIV medical providers’ knowledge of ACA
September 23, 2018 - Oxehealth secures European medical device accreditation for vital signs measurement software
September 23, 2018 - HTN Tx Intensification Common Upon Discharge in U.S. Vets
T1D with Eye Disorder, CKD Tied to Heart Complications

T1D with Eye Disorder, CKD Tied to Heart Complications

image_pdfDownload PDFimage_print

Action Points

  • Chronic kidney disease (CKD) and proliferative diabetic retinopathy (PDR) in people with type 1 diabetes may be tied to microvascular complications.
  • Note that PDR was also independently tied to cardiovascular disease among patients with type 1 diabetes and CKD, while CKD without PDR was not tied to cardiovascular disease risk.

Chronic kidney disease and proliferative diabetic retinopathy in people with type 1 diabetes may be tied to microvascular complications, researchers reported.

Among older patients with type 1 diabetes, cardiovascular disease prevalence was 68.2% among those with both chronic kidney disease (CKD) and proliferative diabetic retinopathy (PDR). This was significantly higher compared to patients who only had CKD (34.5%) or PDR (42.8%) (P=0.002), according to Daniel Gordin, MD, PhD, of Joslin Diabetes Center in Boston, and colleagues.

The lowest prevalence of cardiovascular disease was seen in patients without either CKD or PDR (28.8%), they wrote in Diabetes Care.

However, PDR was also independently tied to cardiovascular disease among patients with type 1 diabetes and CKD (OR 0.21, 95% CI 0.08-0.58, P=0.003), while CKD without PDR was not tied to cardiovascular disease risk.

“The co-occurrence of CKD and PDR is not surprising since chronic hyperglycemia is the major contributor to diabetic microvascular complications,” the group wrote.

However, “these unexpected findings suggest that PDR adds to the toxicity of chronic kidney disease in the development of cardiovascular disease, or that there could be a common protective factor against hyperglycemic toxicity for severe diabetic eye disease and CVD,” they added.

A total of 762 individuals who participated in the Joslin Medalist Study were included in the current cross-sectional analysis. All participants had type 1 diabetes with insulin treatment for 50 years or more.

Estimated glomerular filtration rate was determined using the Chronic Kidney Disease Epidemiology Collaboration formula, while CKD was defined as stage 3b CKD (eGFR <45 mL/min/1.73m2). PDR was determined using the Early Treatment Diabetic Retinopathy Study (ETDRS) protocol, defined as a score of over 53.

Among the cohort, the majority of individuals did not have CKD but did have PDR (n=339). The second largest group included those without CKD and PDR (n=327), while there were 66 individuals with both conditions. Although all groups had no significant differences in HbA1c levels, those with CKD and without PDR were notably older at the time of type 1 diabetes diagnosis. This group also had the highest prevalence of random detectable C-peptide versus all other groups.

A secondary analysis was also performed by the group, which included 675 individuals with type 1 diabetes for 25 years or more from the FinnDiane Study. This study utilized the same definition for CKD, while PDR was defined as a score of 60 or greater on the ETDRS scale.

This analysis found similar trends as the Medalist cohort, with a trend towards a lower prevalence of cardiovascular disease seen among the group with CKD but without PDR (19.1%) versus those with both conditions (37.1%, P=0.10). The group noted this relationship likely didn’t reach significance “due to small sample size and number of events.”

Similar to the Medalist study, the lowest prevalence of cardiovascular disease was seen in the group without either CKD or PDR (6.6%).

“Multiple possible factors could be involved in this differential protection on the retinal, renal and cardiovascular tissue in diabetes,” the authors suggested. “Of particular interest could be insulin and vascular endothelial growth factor (VEGF), which have been targets of therapeutic modulations for all three complications.”

“Interestingly, VEGF expressions are elevated in the retina and renal glomeruli, yet decreased by diabetes in the myocardium. This differential tissue expression of VEGF in diabetes made systemic treatments targeting VEGF difficult, but may provide an explanation for differential contributions to CKD, PDR, and neuropathy in addition to CVD.”

Study limitations included the long duration of type 1 diabetes in patients from both cohorts. The authors suggested future studies include patients with a shorter duration of diabetes aimed at determining whether CKD with PDR “is a marker of more generalized vascular dysfunction or whether tissue specific protective factors are in play.”

Click here for the American Association of Clinical Endocrinologists’ clinical practice guidelines for developing a diabetes mellitus comprehensive care plan.

The study was supported by the Iacocca Foundation, the Folkhälsan Research Foundation, the Wilhelm and Else Stockmann Foundation, the Livoch Hälsa Foundation, The Medical Society of Finland (Finska Läkaresällskapet), the Finnish Medical Foundation, The Swedish Cultural Foundation in Finland, the Biomedicum Helsinki Foundation, the Dorothea Olivia, Karl Walter och Jarl Walter Perkléns Foundation, Academy of Finland, Novo Nordisk Foundation, Päivikki and Sakari Sohlberg Foundation, and by EVO governmental grants.

Gordin disclosed no relevant relationships with industry. One co-author disclosed relevant relationships with Eli Lilly, Roche, AbbVie, Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Medscape, MSD, Novartis, and Sanofi, Genzyme, Novartis, Novo Nordisk, and Sanofi.

  • Reviewed by
    Robert Jasmer, MD Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2018-01-02T00:00:00-0500

last updated

Tagged with:

About author

Related Articles